Literature DB >> 6441067

Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy.

R M Valentijn, J Radl, J J Haaijman, B J Vermeer, J J Weening, R H Kauffmann, M R Daha, L A van Es.   

Abstract

In a prospective study of 38 patients who presented with hematuria of renal origin, 15 patients were found to have primary IgA nephropathy and 23 had other renal disorders. Sera and renal biopsy specimens of these patients were studied for the presence of macromolecular IgA1 and IgA2 using monoclonal antibodies, and the presence of J-chain as demonstrated either by immunofluorescence or its capacity to bind free secretory component. Circulating macromolecular IgA was found exclusively in the sera of patients (80%) with primary IgA nephropathy. In these sera the polymer/monomer ratio for IgA1 (0.64 +/- 0.13) was significantly higher than for normal human serum (0.39 +/- 0.01) (P less than 0.001), while no differences were found for IgA2. The polymeric IgA1 was isolated from serum by gel chromatography and was shown to have the capacity to bind free secretory component. Direct two-color immunofluorescence studies revealed the presence of only IgA1 in the mesangial deposits and also its capacity to bind free secretory component. We conclude (1) that demonstration of circulating macromolecular IgA in patients with renal hematuria is of diagnostic value and (2) that antigenetic similarities between the circulating and the mesangial macromolecular IgA suggest that dimeric IgA1 is deposited in the mesangium of patients with primary IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441067     DOI: 10.1038/ki.1984.213

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

Review 1.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

3.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV).

Authors:  F Müller; S S Frøland; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 5.  Pathology of IgA nephropathy.

Authors:  Ian S D Roberts
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

6.  Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.

Authors:  F P Schena; A Pastore; N Ludovico; R A Sinico; S Benuzzi; V Montinaro
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

7.  [Alcohol and IgA in the kidney].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1985-09-16

8.  IgA and IgG immune complexes increase human macrophage C3 biosynthesis.

Authors:  J Laufer; H Boichis; N Farzam; J H Passwell
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

9.  Circulating IgA immune complexes and skin IgA deposits in liver disease. Relation to liver histopathology.

Authors:  A van de Wiel; R M Valentijn; H J Schuurman; M R Daha; R J Hené; L Kater
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

10.  An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Authors:  R K Stad; J A Bruijn; D J van Gijlswijk-Janssen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.